Echo Therapeutics, Inc. Debt Instrument, Convertible, Beneficial Conversion Feature
Echo Therapeutics, Inc. reported Debt Instrument, Convertible, Beneficial Conversion Feature of -$1.86 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-16.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2016-11-16
- Echo Therapeutics, Inc. debt instrument, convertible, beneficial conversion feature for the quarter ending 2016-09-30 was $0.00.
- Echo Therapeutics, Inc. debt instrument, convertible, beneficial conversion feature for the quarter ending 2016-06-30 was -$1.71M.
- Echo Therapeutics, Inc. debt instrument, convertible, beneficial conversion feature for the quarter ending 2016-03-31 was -$154.59K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month | Debt Instrument, Convertible, Beneficial Conversion Feature 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-16 | -$1.71M derived: sum of 2 quarters · filed 2016-11-16 | -$1.86M 10-Q · filed 2016-11-16 |
| 2016-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$1.86M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$154.59K 10-Q · filed 2016-05-20 |